DexCom, Inc. vs Progressive Corp — how do they compare? DexCom, Inc. trades at $77.95 (market cap $28.06B), while Progressive Corp trades at $203.51 (market cap $119.48B). The key difference: Progressive Corp is far larger — about 4.3× DexCom, Inc.'s market cap, and Progressive Corp pays a 6.77% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | PGR | |
|---|---|---|
Market Cap | $28.06B | $119.48B |
Sector | Health | Financials |
52-Week High | $89.53 | $252.68 |
52-Week Low | $54.84 | $190.40 |
Enterprise Value | $27.03B | $127.70B |
Dividend Yield | — | 6.77% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Progressive (PGR) trades at $203.56, down 10.16% over 24 hours, reflecting bearish technical signals and recent earnings misses. The stock shows strong fundamentals with a P/E of 10.3, net income margin of 12.93%, and robust revenue growth from $49.6B in 2022 to $87.6B in 2025. Analyst consensus is mixed with a $238.56 price target, while recent news highlights Q2 2026 earnings beating estimates but facing profit decline concerns.
The outlook balances solid profitability and valuation appeal against technical weakness and earnings volatility. Key opportunities include attractive multiples and operational strength, while risks involve competitive pressures and market sentiment shifts. Investors should weigh fundamental resilience against near-term price pressure.
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →